Presidio Property Trust 9.375% Perpetual Preferred Stock Series D (SQFTP)

Overview

Presidio is a diversified Real Estate Investment Trust (REIT) with a unique portfolio that primarily encompasses model home properties triple-net leased to homebuilders. Along with its specialized focus on model homes, Presidio diversifies its investment through ownership in office, industrial, and retail properties. This strategic real estate mix spans several key states in the U.S., including Arizona, Illinois, Texas, Wisconsin, Florida, Colorado, Maryland, North Dakota, and Southern California. The company's strategy of geographical clustering allows it to achieve economies of scale, lowering operating costs by managing multiple properties with fewer resources. However, this strategy also brings with it the risk of exposure to regional market fluctuations, a concern that has been heightened by the ongoing impacts of COVID-19. Moreover, Presidio extends its diversification beyond real estate by holding a significant stake in Conduit Pharmaceuticals Inc., allowing the company to venture into the healthcare sector by investing in a promising clinical-stage life science entity.

Products and Services

• Model Home Properties Triple-Net Leased to Homebuilders

Presidio's core investment focus, these model homes provide a stable revenue stream through long-term, triple-net leases with homebuilders. Primarily located in Arizona, Illinois, Texas, Wisconsin, and Florida, these properties not only yield consistent income but also benefit from the strength and stability of the housing market in these geographically diverse locations.

• Office, Industrial, and Retail Properties

Expanding beyond model homes, Presidio owns and manages a variety of office, industrial, and retail spaces. These properties are predominantly situated in Colorado, providing a solid base of operations, with additional assets in Maryland, North Dakota, Texas, and Southern California. This variation in property type and location serves to mitigate risk by spreading investment across different sectors of the real estate market.

• Investment in Conduit Pharmaceuticals Inc.

In a strategic move to diversify its investments, Presidio holds an approximately 6.5% ownership stake in Conduit Pharmaceuticals Inc. This collaboration with a disease-agnostic, multi-asset, clinical-stage life science company marks Presidio's venture into the healthcare sector. Conduit Pharmaceuticals is known for its efficient model for compound development, representing an innovative approach to tackling diverse diseases and conditions.